Recurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs—a primary or secondary entity?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical Rheumatology

• Publication date

  2017-05-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10067-017-3670-1PMID 28488125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency

  2016cited by this paper
• Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy.

  2016cited by this paper
• Rheumatologic manifestations of primary immunodeficiency diseases

  2016cited by this paper
• International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

  2016cited by this paper
• Intravenous and subcutaneous immunoglobulin G replacement therapy.

  2016cited by this paper
• Rates of Cancers and Opportunistic Infections in Patients With Psoriatic Arthritis Compared With Patients Without Psoriatic Arthritis

  2016cited by this paper
• Clinical picture and treatment of 2212 patients with common variable immunodeficiency.

  2014cited by this paper
• Should mild hypogammaglobulinemia be managed as severe hypogammaglobulinemia? A study of 389 patients with secondary hypogammaglobulinemia.

  2014cited by this paper
• Common variable immunodeficiency and autoimmunity--an inconvenient truth.

  2014cited by this paper
• Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes.

  2014cited by this paper
• Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency.

  2012cited by this paper
• Recurrent infections in a rheumatoid arthritis patient with a primary immunodeficiency, treated with conventional and biologic disease-modifying anti-rheumatic drugs

  2012cited by this paper
• Diagnostic strategy for patients with hypogammaglobulinemia in rheumatology.

  2011cited by this paper
• Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study.

  2011cited by this paper
• Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

  2010cited by this paper
• Infectious complications of biological therapy

  2009cited by this paper
• Serum immunoglobulins and risk of infection: how low can you go?

  2009cited by this paper
• Preparation and use of therapeutic antibodies primarily of human origin.

  2008cited by this paper
• Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

  2008cited by this paper
• Rheumatoid arthritis in a patient with common variable immunodeficiency:difficulty in diagnosis and therapy

  2006cited by this paper
• Bone and joint disease associated with primary immune deficiencies.

  2005cited by this paper
• Common variable immunodeficiency mimicking rheumatoid arthritis with Sjögren's syndrome.

  2005cited by this paper

• Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis

  2022cites this paper
• Hypogammaglobulinaemia in identical twin sisters with rheumatoid arthritis.

  2020cites this paper
• From infections to autoimmunity: Diagnostic challenges in common variable immunodeficiency

  2020cites this paper